Fingerprint
Dive into the research topics of 'FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphoma
Olga V. Danilova, Larry J. Dumont, Norman B. Levy, Frederick Lansigan, William B. Kinlaw, Alexey V. Danilov, Prabhjot Kaur
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations